TipRanks
Go Ultimate55% OFF

Halozyme (RV7) Ownership - Who Owns Halozyme?

Halozyme (RV7) Ownership Overview

  • 0.92% Insiders
  • 30.45% Mutual Funds
  • 6.76% Other Institutional Investors
  • 30.49% ETFs
  • 31.37% Public Companies and Individual Investors

The ownership structure of Halozyme (DE:RV7) stock is a mix of institutional, retail, and individual investors. Approximately 67.71% of the company’s stock is owned by Institutional Investors, 0.92% is owned by Insiders, and 31.37% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Mar 09, 2026Cortney Caudill$1,955,137

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Dec 31, 2025Pzena Investment Management Llc€287,909
Dec 31, 2025Gallacher Capital Management Llc€433,883
Dec 31, 2025Hussman Strategic Advisors Inc€3,533,250
Dec 31, 2025Royce & Associates Llc€4,509,100

Top Shareholders

DE:RV7 top shareholders
Holder# of SharesType% HoldingValue
BlackRock, Inc.13,271,095Institution11.69%1,692,821,065
Ishares13,074,162Institution11.52%1,667,700,882
Vanguard9,916,077Institution8.74%1,264,865,034
Vanguard Index Funds9,410,725Institution8.29%1,200,403,849
Spdr3,760,748Institution3.31%479,709,733
Delaware Group Equity Funds V3,056,123Institution2.69%389,829,882
First Trust1,489,880Institution1.31%190,044,623
John Hancock Funds Iii1,430,565Institution1.26%182,478,580
Dfa1,279,605Institution1.13%163,222,575
T. Rowe Price Quantitative Management Funds, Inc.1,175,300Institution1.04%149,917,742

Top Mutual Fund Holders

DE:RV7 top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds9,410,725Institution8.29%1,200,403,849
Delaware Group Equity Funds V3,056,123Institution2.69%389,829,882
John Hancock Funds Iii1,430,565Institution1.26%182,478,580
T. Rowe Price Quantitative Management Funds, Inc.1,175,300Institution1.04%149,917,742
Fidelity Concord Street Trust1,174,751Institution1.04%149,847,713
Capitol Series Trust1,141,605Institution1.01%145,619,709
Tiaa-cref Funds1,011,291Institution0.89%128,997,246
Vanguard Explorer Fund832,286Institution0.73%106,163,905
Fidelity Salem Street Trust759,139Institution0.67%96,833,493
Dfa Investment Dimensions Group Inc756,531Institution0.67%96,500,825

FAQ

Who Owns Halozyme (DE:RV7)?
According to the latest TipRanks data, approximately 67.71% of the company's stock is held by institutional investors, 0.92% is held by insiders, and 31.37% is held by public companies and individual investors.
What percentage of Halozyme (DE:RV7) stock is held by institutional investors?
According to the latest TipRanks data, approximately 67.71% of Halozyme (DE:RV7) stock is held by institutional investors: 30.45% by mutual funds, 30.49% by ETFs and 6.76% by other institutional investors.
What percentage of Halozyme (DE:RV7) stock is held by retail investors?
According to the latest TipRanks data, approximately 31.37% of Halozyme (DE:RV7) stock is held by public companies and individual investors.
Who owns the most shares of Halozyme (DE:RV7)?
BlackRock, Inc. owns the most shares of Halozyme (DE:RV7).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.